FCM
LLY icon

Fieldview Capital Management’s Eli Lilly LLY Stock Holding History

Fieldview Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Buy
+168
New +$172K 0.06% 493
2025
Q3 		– Sell
-343
Closed -$267K – 472
2025
Q2 		$267K Buy
+343
New +$267K 0.04% 299

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fieldview Capital Management's LLY Position: Q2 2026 in Review

Fieldview Capital Management opened a new position in Eli Lilly (LLY) in Q2 2026: 168 shares worth $202K. The stake represents 0.06% of the portfolio and ranks #493 among its holdings. This is a return to the name: Fieldview Capital Management previously reported a position in LLY as recently as Q2 2025.

Fieldview Capital Management first reported a position in LLY in Q2 2025 and has held it in 2 quarters since. The position peaked at $267K in Q2 2025. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Fieldview Capital Management held 168 shares of Eli Lilly worth $202K as of Q2 2026.
  • Eli Lilly was a new Fieldview Capital Management position in Q2 2026.
  • Eli Lilly made up 0.06% of Fieldview Capital Management's portfolio in Q2 2026, its #493 holding.
  • Fieldview Capital Management first reported a position in Eli Lilly in Q2 2025 and has held it in 2 quarters since.
  • Fieldview Capital Management's Eli Lilly position peaked at $267K in Q2 2025.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Fieldview Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.